Genome editing in non-model organisms opens new horizons for comparative physiology by Dickinson, Michael H. et al.
EDITORIAL
Genome editing in non-model organisms opens new horizons
for comparative physiology
Michael H. Dickinson1, Leslie B. Vosshall2,3,4 and Julian A. T. Dow5,*
For almost 100 years, biologists have made fundamental discoveries
using a handful of model organisms that are not representative of the
rich diversity found in nature. The advent of CRISPR genome
editing now opens up a wide range of new organisms to mechanistic
investigation. This increases not only the taxonomic breadth of
current research but also the scope of biological problems that are
now amenable to study, such as population control of invasive
species, management of disease vectors such as mosquitoes, the
creation of chimeric animal hosts to grow human organs and even
the possibility of resurrecting extinct species such as passenger
pigeons and mammoths. Beyond these practical applications, work
on non-model organisms enriches our basic understanding of the
natural world. This special issue addresses a broad spectrum of
biological problems in non-model organisms and highlights the
utility of genome editing across levels of complexity from
development and physiology to behaviour and evolution.
The study of physiology and genetics has typically been via binary
alternative pathways, chosen early in university education. This is a
shame because the synthesis of these disciplines is preciselywhere the
most exciting biology is to be found. Physiologists try to understand
how the organism works, by painstaking experimental and
pharmacological interventions, continually working to minimize
artefacts inducedby the protocols themselves.Geneticists, by contrast,
bring the twin approaches of forward and reverse genetics: forward
mutagenic screens allow unbiased discovery of genes that impact a
phenotype of interest, whereas reverse genetics uses molecular
biology to deduce the function of a genebymutating it and looking for
a detectable phenotype. Until recently, the separation of physiological
and genetic approaches has limited the progress that can be made in
either of these individual fields. Physiologists have been slow to adopt
the gene-based molecular and reverse genetic approaches that were
available in ‘model’ organisms, whereas geneticists have been limited
to studying the general problems accessible in model organisms,
losing out on the richness of specialized behaviours and
developmental mechanisms found in the rest of the tree of life.
Over the past couple of decades, some more intrepid researchers
from both camps have worked to close this acknowledged gap
by embracing the features and limitations of model organisms.
Although these approaches have been fraught with difficulties – fly,
worm, zebrafish and mouse are scarcely the biggest representatives
of their respective clades – these efforts have generally been
transformative in their fields. However, the mismatch remains.
Model organisms remain few and far between in phylogenetic space,
and it can be hard to convince a salmon specialist that zebrafish is a
good model for adaptation to varying salinity, or a mosquito vector
biologist that Drosophila melanogaster is suitable for studying
blood-feeding behaviour.
Hence the excitement that this special issue tries to capture. Here,
we assemble papers on the great democratizing technology of
genome editing, and in particular CRISPR. Suddenly, the reverse
genetic approach becomes accessible in ‘target’, rather than
classical ‘model’ organisms. Many of the elegant manipulations
of modern genetics – single base mutations, gene deletions, GFP
fusions and so on, become feasible in a wider array of organisms.
This is not the same as ‘easy’; it is important to acknowledge that
organisms vary hugely in the ease with which gene targeting
technology can be applied. However, it is now at least possible, and
this special issue illustrates work in organisms as diverse as
mosquitoes, cattle, parasitic nematodes, and sticklebacks. The
papers further illustrate nicely the versatility of this approach, with
topics ranging from molecular evolution to pest control and from
control of reproduction to ageing.
Do the advantages of gene editing make our familiar models –
yeast, worm, fly, fish and mouse – obsolete? Perhaps the opposite. As
nicely documented in Benjamin Matthews’ paper ( jeb218198), the
path to becoming an all-round model requires the development of a
huge range of complementary technologies, such as online
informatic resources, genomes, transgenic resources, stock centres
and cell-specific transgenic interventions like the Gal4/UAS
system. Whereas an individual lab can maintain a thousand
Drosophila melanogaster stocks (and a reference stock centre over
20,000), it is a major undertaking tomaintain a stable stock ofmalaria
mosquitoes, let alone more than a few dozenmutants. And, of course,
establishedmodels comewith a prior art that can reach back a century
and encompass hundreds of thousands of papers. In this context,
‘model hopping’ becomes an attractive paradigm. Study of a ‘target’
organism can be accelerated by referring back to the phylogenetically
closest geneticmodel, finding out what is already known about a gene
of interest, and perhaps experimenting with existing mutant or RNAi
resources. This relatively quick and inexpensive comparative work
canhelp to framea strategy for transgenic experimentation in the target
species of interest, or even suggest whether such work is needed.
Overall, new technologies associated with genome editing have
spawned a new age for comparative physiology. Krogh’s famous
principle (though uncannily similar to that posited by Claude
Bernard in 1865) ‘For such a large number of problems there will be
some animal of choice or a few such animals on which it can be
most conveniently studied’, has underpinned modern comparative
physiology. Now many more organisms can be ‘Krogh organisms’,
and comparative physiology can ask a whole range of new, truly
comparative questions about the logic of life, with access to a hugely
expanded toolbox. We hope this special issue will help to convey
some of this excitement.
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